Genome sequence and characterization of a hypervirulent BI/NAP1/027 Clostridioides difficile (CDC20121308)
Laureano Ángel EspañoliD, Miranda Clara PalumboiD, Angela María BarberoiD, Sabina PalmaiD, Federico SerraliD, Diego Ruggeri, Marcelo Adrian MartiiD, Darío Fernández Do PortoiD, Rodrigo Emanuel Hernández Del PinoiD, Virginia PasquinelliiD
Abstract
Clostridioides difficile is a gram-positive bacterium implicated in antibiotic-associated diarrhea. The use of antibiotics alters the gut microbiota, rendering the host susceptible to infection by C. difficile. This pathogen colonizes the large intestine of humans and animals leading to asymptomatic carriage or clinical manifestations such as toxic megacolon and fulminant colitis depending on a wide range of pathogen and host factors. The emergence of BI/NAP1/027 strains in North America and the spread of these hypervirulent ribotypes worldwide have been linked to the increase in incidence and severity of C. difficile infections (CDI) over the last decade. In this work, we aimed to characterize the BI/NAP1/027 C. difficile commercial strain CDC20121308 widely employed in the study of host-pathogen interactions. The genome sequence was obtained using a whole-genome shotgun strategy. A total of 3,717 coding sequences (CDS) and 45 tRNAs were predicted. The annotation of the CDC20121308 strain identified 26% of CDS into RAST subsystems. We also detected the presence of RT 027 lineage markers such as thyA, cdtA, cdtB and tcdC 18bp-deletion. Moreover, the genome of CDC20121308 had 11 genes devoted to resistance to toxic compounds, antibiotics (e.g. Tetracycline (Tet) and Vancomycin (Van)) and disinfecting agents as predicted using CARD. C. difficile CDC20121308 resistance to Van and Tet was confirmed by broth microdilution assay. Crystal violet staining demonstrated biofilm formation, which could be associated with antibiotic resistance and pathogenicity. Additionally, we observed a spreading diffuse growth in soft agar tubes, suggesting a motile phenotype. Lastly, a genomic region containing Type 4 Secretory System components such as virD4, virB4, and virB6 was identified. In conclusion, our results allowed a genomic and functional characterization of the BI/NAP1/027 C. difficile CDC20121308 strain. We demonstrated the presence of several genes associated with pathogenesis that were validated by experimental assays. This study provides additional data for the use of this highly virulence commercial strain of epidemiological relevance in research works involving in vitro and in vivo approaches.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Protection against Clostridioides difficile disease by a naturally avirulent C. difficile strain
Qiwen Dong, Stephen Harper, … Eric G. Pamer·Cell Host & MicrobePeer-reviewed·Nov 27, 2024
- Virulence and genomic diversity among clinical isolates of ST1 (BI/NAP1/027) Clostridioides difficile
Q. Dong, H. Lin, … E. G. Pamer·bioRxiv·Jan 12, 2023
- Characterization of the clade 4 non-toxigenic C. difficile isolate L-NTCD03 carrying the cfr(B) gene
Britt Nibbering, Sam Nooij, … Wiep Klaas Smits·FEMS MicrobesPeer-reviewed·Jan 1, 2026
- Phylogenomic analysis of Clostridiodes difficile ribotype 106 strains reveals novel genetic islands and emergent phenotypes
Bryan P. Roxas, Jennifer Lising Roxas, … Gayatri Vedantam·Scientific ReportsPeer-reviewed·Dec 17, 2020
- Low-Toxin Clostridioides difficile RT027 Strains Exhibit Robust Virulence
F. Anwar, B. A. P. Roxas, … G. Vedantam·bioRxiv·Mar 18, 2022
- A species-wide genetic atlas of antimicrobial resistance in Clostridioides difficile
K. Imwattana, C. Rodriguez, … D. R. Knight·bioRxiv·Jun 14, 2021